📰 2 sources covering this story

Major bank CEO says company spends $250 million a year on GLP-1 drugs for its employees

First covered 1 days ago · latest take 2 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Major bank CEO says company spends $250 million a year on GLP-1 drugs for its employees
Major bank CEO says company spends $250 million a year on GLP-1 drugs for its employees
GLP-1 drugs for weight loss are on the rise, with 11 percent of Americans saying they take one in a recent poll
CNBC
CNBC🏁 first to report1 days ago
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →